Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 70Unknown 29Terminated 13Withdrawn 3Active not recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 2Gynecologic 1

Conditions

Fatigue 2Breast Neoplasms 2Sleep Wake Disorders 1Ovarian Neoplasms 1Depression 1Carcinoma, Ovarian Epithelial 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Amplified Fragment Length Polymorphism Analysis × Clear all
NCT00903214 2013-04-29

Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer

Barbara Ann Karmanos Cancer Institute

Phase 1 Withdrawn
Breast

Breast Neoplasms

NCT00914043 2013-01-11

Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45

NSABP Foundation Inc

Withdrawn
Breast

Breast Neoplasms, Fatigue

NCT00460200 2012-10-04

Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer

Jonsson Comprehensive Cancer Center

Withdrawn
Gynecologic

Carcinoma, Ovarian Epithelial, Depression, Fatigue, Ovarian Neoplasms, Sleep Wake Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡